Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Expansion of CD56dimCD16neg NK Cell Subset and Increased Inhibitory KIRs in Hospitalized COVID-19 Patients
José L. Casado, Elisa Moraga, Pilar Vizcarra, et al.
Viruses (2021) Vol. 14, Iss. 1, pp. 46-46
Open Access | Times Cited: 19

Showing 19 citing articles:

Defining the role of natural killer cells in COVID-19
Madeline Lee, Catherine A. Blish
Nature Immunology (2023) Vol. 24, Iss. 10, pp. 1628-1638
Open Access | Times Cited: 34
Phenotypic Heterogeneity of Dysfunctional Natural Killer Cells During Chronic Infection or Cancer
Kévin Pouxvielh, Marie Marotel, Noëmi Rousseaux, et al.
Springer eBooks (2025), pp. 1-31
Closed Access
NK cellular derived nanovesicles in tumor immunity
Dingru Li, Yixin Shi, Sifei Yu, et al.
Molecular Immunology (2025) Vol. 182, pp. 54-61
Open Access
Exploring the Utility of NK Cells in COVID-19
Xuewen Deng, Hiroshi Terunuma, Mie Nieda
Biomedicines (2022) Vol. 10, Iss. 5, pp. 1002-1002
Open Access | Times Cited: 21
HLA‐DPB1*13:01 associates with enhanced, and KIR2DS4*001 with diminished protection from developing severe COVID‐19
Ticiana D.J. Farias, Silvia Brugiapaglia, Susanna Croci, et al.
HLA (2023) Vol. 103, Iss. 1
Open Access | Times Cited: 9
NK cell subsets and dysfunction during viral infection: a new avenue for therapeutics?
Jacob C. Bjorgen, Jenna K. Dick, Ross Cromarty, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
NK Cell–Monocyte Cross-talk Underlies NK Cell Activation in Severe COVID-19
Madeline Lee, Izumi de los Rios Kobara, Trisha R. Barnard, et al.
The Journal of Immunology (2024) Vol. 212, Iss. 11, pp. 1693-1705
Open Access | Times Cited: 2
An Update on Protective Effectiveness of Immune Responses After Recovery From COVID-19
Saeede Soleimanian, Soheila Alyasin, Najmeh Sepahi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 11
Redistribution and Activation of CD16brightCD56dim NK Cell Subset to Fight against Omicron Subvariant BA.2 after COVID-19 Vaccination
Huiyun Peng, Tianxin Xiang, Fei Xu, et al.
Microorganisms (2023) Vol. 11, Iss. 4, pp. 940-940
Open Access | Times Cited: 5
Longitudinal transcriptional changes reveal genes from the natural killer cell-mediated cytotoxicity pathway as critical players underlying COVID-19 progression
Matías A. Medina, Francisco Fuentes‐Villalobos, Claudio Quevedo, et al.
eLife (2024) Vol. 13
Open Access | Times Cited: 1
Organ-Dysfunction Markers in Mild-to-Moderate COVID-19 Convalescents
Aleksandra Wiśniewska, Aleksandra Kijak, Karolina Nowak, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 8, pp. 2241-2241
Open Access | Times Cited: 1
Dynamic Evaluation of Natural Killer Cells Subpopulations in COVID-19 Patients
Adina Huțanu, Doina Ramona Manu, Manuela Rozalia Gabor, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11875-11875
Open Access | Times Cited: 5
Longitudinal transcriptional changes reveal genes from the natural killer cell-mediated cytotoxicity pathway as critical players underlying COVID-19 progression
Matías A. Medina, Francisco Fuentes‐Villalobos, Claudio Quevedo, et al.
eLife (2024) Vol. 13
Open Access
Emerging role of natural killer cells in non-AIDS comorbidities during suppressive antiretroviral therapy
Mario Alles, Thorsten Demberg, Namal P. M. Liyanage
Current Opinion in HIV and AIDS (2024)
Closed Access
Comparison of T Lymphocyte Subsets and Natural Killer Lymphocytes in Moderate Versus Severe COVID-19 Patients
Hala Gabr, Asmaa A. Abdel Aal, Samah Bastawy, et al.
Viral Immunology (2023) Vol. 36, Iss. 4, pp. 250-258
Closed Access | Times Cited: 1
NK cell-monocyte crosstalk underlies NK cell activation in severe COVID-19
Madeline Lee, Izumi de los Rios Kobara, TR Barnard, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Diagnostic Value of Natural Killer Cells, CD56+ CD16+ Natural Killer Cells, NLRP3, and Lactate Dehydrogenase in Severe/Critical COVID-19: A Prospective Longitudinal Study According to the Severe/Critical COVID-19 Definitions
Maedeh Radandish, Nafiseh Esmaeil, Farzin Khorvash, et al.
Viral Immunology (2022) Vol. 35, Iss. 9, pp. 616-628
Closed Access | Times Cited: 2
Special Issue “SARS-CoV-2 Innate and Adaptive Immune Responses”
Rémi Planès, Elmostafa Bahraoui
Viruses (2022) Vol. 14, Iss. 11, pp. 2363-2363
Open Access | Times Cited: 1
Redistribution and activation of CD16brightCD56dimNK cell subset to fight against Omicron subvariant BA.2 after COVID-19 vaccination
Yang Liu, Huiyun Peng, Tianxin Xiang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top